Mebucain Orange

Benzoxonium chloride and lidocaine hydrochloride, the active ingredients in Mebucain Orange, are local anesthetics presented as a topical solution for oromucosal use. They provide relief of oral mucosal pain such as mouth ulcers, denture irritation, and sore throat in adults and children.

GNH USA supplies Mebucain Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mebucain Orange, a combination of a quaternary ammonium antiseptic and a local anesthetic, is used for conditions affecting the oral mucosa.

- Mouth ulcers: provides topical pain relief and reduces discomfort. - Denture irritation: alleviates soreness and irritation caused by denture wear. - Sore throat: soothes throat pain associated with minor infections. - Oral mucosal pain: reduces pain from minor injuries or inflammation.

Mebucain Orange may cause local reactions when applied to the oral mucosa.

Common Side Effects: - Mild burning sensation at the application site. - Transient numbness of the treated area. - Altered taste perception. - Mild irritation or redness of the mucosa. - Temporary increased salivation.

Serious or Rare Side Effects: - Allergic reaction such as angioedema or anaphylaxis. - Severe mucosal ulceration or necrosis. - Systemic toxicity from excessive lidocaine absorption. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Persistent dysphagia or airway compromise.

Before using Mebucain Orange, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: limited data are available; use only if benefits outweigh potential risks. - Age: safety in children under 2 years has not been established. - Allergy: avoid if known hypersensitivity to benzoxonium chloride, lidocaine, or related compounds. - Concomitant topical anesthetics: do not use with other local anesthetic products to prevent cumulative toxicity. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Mebucain Orange may interact with other medicines; monitor the following.

Major Interactions (Avoid): - Concurrent use with other local anesthetics: increased risk of systemic lidocaine toxicity. - Use with other quaternary ammonium antiseptics: additive mucosal irritation. - Simultaneous systemic lidocaine-containing products: potential for elevated plasma lidocaine levels.

Moderate Interactions (Monitor Closely): - Alcohol‑containing mouthwashes: may enhance burning sensation. - Antihistamines: could mask early signs of an allergic reaction. - CYP450 inhibitors: may reduce lidocaine metabolism, requiring observation for signs of toxicity.